Skip to main content

Advertisement

Log in

Secondary haemophagocytic lymphohistiocytosis triggered by postnatally acquired cytomegalovirus infection in a late preterm infant

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with impairment of cytotoxic T-cells and natural killer cells. Causes in infants are mostly hereditary immune defects as well as various infectious triggering factors, amongst these cytomegalovirus (CMV). Vertical CMV transmission may occur in utero, during birth, and by breast feeding. Usually, a CMV infection transmitted via breast milk is symptomatic only in very immature preterm infants. We report on a late preterm infant born after 35 + 5 weeks of gestation with a birth weight of 1840 g, being admitted to our intensive care unit at the age of 9 weeks with acute enteritis and severe dehydration. After a prolonged recovery, the infant developed a sepsis-like condition with hyperpyrexia, hepatosplenomegaly, and pancytopenia. Combination with high ferritin levels (2809 μg/l), hypertriglyceridaemia (481 mg/dl), elevated soluble IL-2 receptor (sCD25, 9120 U/ml), and reduced perforin expression allowed diagnosis of HLH, caused by an acute CMV infection. Since connatal CMV infection had been ruled out earlier, we report the rare case of secondary HLH triggered by a postnatally acquired symptomatic CMV infection in an immunocompetent infant, most likely transmitted via breast milk. The infant was successfully treated with ganciclovir without need for immunosuppressive therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Janka GE. Hemophagocytic syndromes. Blood Rev. 2007;21:245–53.

    Article  CAS  PubMed  Google Scholar 

  2. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005:82–8.

  3. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31. doi:10.1002/pbc.21039.

    Article  PubMed  Google Scholar 

  4. Janka GE. Hemophagocytic lymphohistiocytosis. Hematology. 2005;10:104–7.

    Article  PubMed  Google Scholar 

  5. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin N Am. 1998;12:435–44.

    Article  CAS  Google Scholar 

  6. Gupta A, Sen R, Batra C, Banerjee D, Gupta A, Jain M. Hemophagocytic syndrome secondary to cytomegalovirus infection in an infant. J Cytol/Indian Acad Cytol. 2011;28:36–8. doi:10.4103/0970-9371.76949.

    Article  Google Scholar 

  7. Imashuku S, Ueda I, Teramura T, Mori K, Morimoto A, Sako M, et al. Occurrence of haemophagocytic lymphohistiocytosis at less than 1 year of age: analysis of 96 patients. Eur J Pediatr. 2005;164:315–9. doi:10.1007/s00431-005-1636-9.

    Article  PubMed  Google Scholar 

  8. Hesseling PB, Wessels G, Egeler RM, Rossouw DJ. Simultaneous occurrence of viral-associated hemophagocytic syndrome and Langerhans cell histiocytosis: a case report. Pediatr Hematol Oncol. 1995;12:135–41.

    Article  CAS  PubMed  Google Scholar 

  9. Olson NY, Olson LC. Virus-associated hemophagocytic syndrome: relationship to herpes group viruses. Pediatr Infect Dis. 1986;5:369–73.

    Article  CAS  PubMed  Google Scholar 

  10. Knorr B, Kessler U, Poschl J, Fickenscher H, Linderkamp O. A haemophagocytic lymphohistiocytosis (HLH)-like picture following breastmilk transmitted cytomegalovirus infection in a preterm infant. Scand J Infect Dis. 2007;39:173–6.

    Article  PubMed  Google Scholar 

  11. Kashiwagi Y, Kawashima H, Sato S, Ioi H, Amaha M, Takekuma K, et al. Virological and immunological characteristics of fatal virus-associated haemophagocytic syndrome (VAHS). Microbiol Immunol. 2007;51:53–62.

    Article  CAS  PubMed  Google Scholar 

  12. Devecioglu O, Anak S, Atay D, Aktan P, Devecioglu E, Ozalp B, et al. Pediatric acute lymphoblastic leukemia complicated by secondary hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2009;53:491–2. doi:10.1002/pbc.22064.

    Article  PubMed  Google Scholar 

  13. Kanhere S, Bhagat M, Kadakia P, Joshi A, Phadke V, Chaudhari K. Hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection in an immunocompetent infant: a diagnostic and therapeutic challenge! Indian J Hematol Blood Transfus. 2014;30:299–302. doi:10.1007/s12288-014-0366-4.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer CP, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 2001;357:513–8.

    Article  CAS  PubMed  Google Scholar 

  15. Stagno S, Reynolds DW, Pass RF, Alford CA. Breast milk and the risk of cytomegalovirus infection. N Engl J Med. 1980;302:1073–6.

    Article  CAS  PubMed  Google Scholar 

  16. Neuberger P, Hamprecht K, Vochem M, Maschmann J, Speer CP, Jahn G, et al. Case–control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants. J Pediatr. 2006;148:326–31.

    Article  PubMed  Google Scholar 

  17. Mehler K, Oberthuer A, Lang-Roth R, Kribs A. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22–24 weeks’ gestation after transmission via breast milk. Neonatology. 2014;105:27–32. doi:10.1159/000355306.

    Article  CAS  PubMed  Google Scholar 

  18. Whitley RJ, Cloud G, Gruber W, Storch GA, Demmler GJ, Jacobs RF, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997;175:1080–6.

    Article  CAS  PubMed  Google Scholar 

  19. Muller A, Eis-Hubinger AM, Brandhorst G, Heep A, Bartmann P, Franz AR. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol. 2008;28:74–6.

    Article  CAS  PubMed  Google Scholar 

  20. Acosta EP, Brundage RC, King JR, Sanchez PJ, Sood S, Agrawal V, et al. Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007;81:867–72.

    Article  CAS  PubMed  Google Scholar 

  21. Frenkel LM, Capparelli EV, Dankner WM, Xu J, Smith IL, Ballow A, et al. Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects. The Pediatric AIDS Clinical Trials Group. J Infect Dis. 2000;182:1616–24.

    Article  CAS  PubMed  Google Scholar 

  22. Kimberlin DW, Jester PM, Sanchez PJ, Ahmed A, Arav-Boger R, Michaels MG, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372:933–43. doi:10.1056/NEJMoa1404599.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Diagnostics were conducted in close cooperation with E.M. Schneider, Department of Experimental Anaesthesiology, University Hospital Ulm, Germany, and G. Janka, Department of Haematology and Oncology, Children’s Hospital, University of Hamburg, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine Silwedel.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Silwedel, C., Frieauff, E., Thomas, W. et al. Secondary haemophagocytic lymphohistiocytosis triggered by postnatally acquired cytomegalovirus infection in a late preterm infant. Infection 45, 355–359 (2017). https://doi.org/10.1007/s15010-016-0970-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-016-0970-3

Keywords

Navigation